The 5 analysts offering 12-month price forecasts for Surface Oncology Inc have a median target of 17.00, with a high estimate of 18.00 and a low estimate of 14.00. The median estimate represents a +296.27% increase from the last price of 4.29.
The current consensus among 6 polled investment analysts is to Buy stock in Surface Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.